Theranostics
Theranostics is a peer-reviewed open access scientific journal (Impact Factor 14.9) covering in vitro diagnostics, molecular imaging, therapeutics, biosensors, and translational medicine, published by Ivyspring International Publisher and indexed by SCI, MEDLINE, PubMed Central, and Europe PMC.
- Company typePrivate
- Founded2011
- HeadquartersSydney, Australia
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Theranostics does
Theranostics is a peer-reviewed open access scientific journal publishing original research in in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology, and translational medicine. The journal is published by Ivyspring International Publisher, a private entity domiciled in New South Wales, Australia, and reports an Impact Factor of 14.9. Full texts are archived in PubMed Central and Europe PMC, and the journal is indexed by the Science Citation Index (SCI) and MEDLINE, ensuring broad global discoverability and full compliance with the NIH Public Access Requirement. New articles are distributed under a Creative Commons Attribution 4.0 International (CC-BY) license, with earlier articles under CC-BY-NC 4.0.
The editorial platform is led by Founding Editor-in-Chief Prof. Xiaoyuan (Shawn) Chen (H-index 219, approximately 180,000 citations; Clarivate Highly Cited Researcher for eight consecutive years), whose scientific standing in nuclear medicine, molecular imaging, and nanomedicine anchors the journal's submission quality and reputation. The publisher operates a broader journal portfolio (Nanotheranostics, International Journal of Biological Sciences, International Journal of Medical Sciences, Journal of Cancer) that creates cross-referencing and shared infrastructure leverage.
The business model centers on open access publishing of peer-reviewed articles supplemented by themed Special Issues (e.g., precision oncology, targeted nanotherapeutics). The customer base spans academic and research institutions, clinical and medical professionals, and biotech and pharmaceutical industry researchers — a horizontal, distributed set with no disclosed enterprise anchor accounts. Headcount is reported at 11-50 employees. Pricing details, including any article processing charges, are not publicly disclosed in the source material, and no funding events, M&A activity, or financial metrics were found.
Theranostics firmographics
Firmographics- Name
- Theranostics
- Legal name
- Ivyspring International Publisher
- Website
- https://thno.org
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Theranostics is a peer-reviewed open access scientific journal (Impact Factor 14.9) covering in vitro diagnostics, molecular imaging, therapeutics, biosensors, and translational medicine, published by Ivyspring International Publisher and indexed by SCI, MEDLINE, PubMed Central, and Europe PMC.
- Ownership category
- akta.pro rank
Theranostics industry classification
Industry- Product category
- Scientific Journal Publishing
- NAICS
- Periodical Publishers (513120)
- akta.pro primary industry
- Medical, Clinical & Biomedical Scholarly Publishing (EDAGAFAB)
- akta.pro secondary industry
- Medical & Clinical Reference (Physicians, Nursing, Allied Health) (EDAGAGAA)
Keywords
Where Theranostics is headquartered
LocationHeadquarters
- HQ city
- Sydney
- HQ country
- Australia
- HQ region
- Oceania
Markets served
Theranostics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Distribution channels4 records
Marketing channels3 records
Theranostics product offering
Product offeringCore offering
Theranostics is a peer-reviewed open access scientific journal that publishes original research articles, reviews, and themed special issues across in vitro diagnostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology, and translational medicine. The journal is published by Ivyspring International Publisher under Creative Commons licensing, with an Impact Factor of 14.9, and is indexed in SCI, MEDLINE, PubMed Central, and Europe PMC for global readership.
Product overview
Theranostics is a single academic journal published by Ivyspring International Publisher. The platform offers one core product: the Theranostics Journal, an international peer-reviewed open access publication with an Impact Factor of 14.9. The journal covers biomedical research including in vitro diagnostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology, and translational medicine. Special themed issues provide focused collections on specific research topics. No SaaS platform, modules, or add-on products are offered.
Differentiator
Problem solved
Functional benefit
Products and services
- Theranostics Journal International peer-reviewed open access journal publishing innovative research across in vitro diagnostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology, and translational medicine, with an Impact Factor of 14.9 and indexing in SCI, MEDLINE, PubMed Central, and Europe PMC.
- Theranostics Special Issues
Quantifiable outcome
- Impact Factor: 14.9
- +1 more outcomes
Companies that use Theranostics
Customer profileSegments3 records
Ideal customer profiles3 records
Theranostics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Theranostics partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights3 records
Theranostics competitors and assessment
Company assessmentMarket position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Theranostics social profiles
Digital presenceTheranostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Theranostics leadership team
Management profileNumber of profiles
Profiles1 record
Theranostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Theranostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Theranostics
What does Theranostics do?
Theranostics is a peer-reviewed open access scientific journal that publishes original research articles, reviews, and themed special issues across in vitro diagnostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology, and translational medicine. The journal is published by Ivyspring International Publisher under Creative Commons licensing, with an Impact Factor of 14.9, and is indexed in SCI, MEDLINE, PubMed Central, and Europe PMC for global readership.
Is Theranostics a public or private company?
Theranostics is a private company. It is classified as unknown and is currently operating.
When was Theranostics founded?
Theranostics was founded in 2011. It employs 11 to 50 people.
Where is Theranostics based?
Theranostics is headquartered in Sydney, Australia, in the Oceania region.
Does Theranostics have an API?
No public API is recorded for Theranostics.
What industry is Theranostics in?
Theranostics's product category is Scientific Journal Publishing. Its primary akta.pro industry code is EDAGAFAB, Medical, Clinical & Biomedical Scholarly Publishing, with a secondary code of EDAGAGAA, Medical & Clinical Reference (Physicians, Nursing, Allied Health). Its NAICS code is 513120.